1. Home
  2. Our Firm
  3. News
  4. CNBC: Guggenheim’s Schwartz Sees Pickup in M&A Activity

Our Firm

April 29, 2014

CNBC: Guggenheim’s Schwartz Sees Pickup in M&A Activity

Guggenheim Partners Executive Chairman Alan Schwartz said in an interview with CNBC’s Brian Sullivan at the Milken Institute Global Conference that investors should expect a surge in global merger and acquisition activity.

“There has been a lot of M&A dialog in the boardroom for several years and I think it has taken longer to get over the finish line and a lot of deals don’t get done. So I think we are seeing that backlog come to the forefront and I think it will last a while,” Schwartz said.

Schwartz added there were many new companies in the new economy and leveraged buyouts that would want to go public but that deals would depend on market appetite.



July 17, 2018

Whitney Ijem Joins Guggenheim Securities as Biotech Analyst

Guggenheim Securities announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.

Read More

July 12, 2018

Guggenheim Securities Hires Jordan Bliss to Expand Healthcare Investment Banking Group

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jordan Bliss will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group. Mr. Bliss will focus on advising companies in the life sciences sector and will be based in Guggenheim’s San Francisco office.

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.